Free Trial

XOMA (XOMA) SEC Filings & 10K Form

XOMA logo
$23.52 -1.02 (-4.16%)
Closing price 04:00 PM Eastern
Extended Trading
$23.52 0.00 (-0.02%)
As of 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent XOMA SEC Filings

DateFilerForm TypeView
02/11/2025
7:26 AM
XOMA (Filer)
XOMA Royalty Corp (Filer)
XOMA Royalty Corp (Filer)
Form 8-K/A
01/28/2025
4:23 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
XOMA (Issuer)
XOMA Royalty Corp (Issuer)
XOMA Royalty Corp (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
4:19 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
XOMA (Subject)
XOMA Royalty Corp (Subject)
XOMA Royalty Corp (Subject)
Form SCHEDULE 13D/A
01/10/2025
3:30 PM
Sitko Bradley (Reporting)
XOMA (Issuer)
XOMA Royalty Corp (Issuer)
XOMA Royalty Corp (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
8:58 AM
XOMA (Filer)
XOMA Royalty Corp (Filer)
XOMA Royalty Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
5:55 PM
Hughes Owen (Reporting)
XOMA (Issuer)
XOMA Royalty Corp (Issuer)
XOMA Royalty Corp (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
5:55 PM
BURNS THOMAS M. (Reporting)
XOMA (Issuer)
XOMA Royalty Corp (Issuer)
XOMA Royalty Corp (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:45 AM
XOMA (Filer)
XOMA Royalty Corp (Filer)
XOMA Royalty Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:35 AM
XOMA (Filer)
XOMA Royalty Corp (Filer)
XOMA Royalty Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
7:16 AM
XOMA (Filer)
XOMA Royalty Corp (Filer)
XOMA Royalty Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
5:35 AM
XOMA (Filer)
XOMA Royalty Corp (Filer)
XOMA Royalty Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
6:45 AM
XOMA (Filer)
XOMA Royalty Corp (Filer)
XOMA Royalty Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
6:36 AM
XOMA (Filer)
XOMA Royalty Corp (Filer)
XOMA Royalty Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/09/2024
7:00 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
11:15 PM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form EFFECT
06/17/2024
11:15 PM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form EFFECT
06/13/2024
3:31 PM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K/A
05/30/2024
3:43 PM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
3:30 PM
LIMBER JOSEPH M (Reporting)
XOMA (Issuer)
XOMA Corp (Issuer)
XOMA Corp (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:30 PM
PERRY MATTHEW D (Reporting)
XOMA (Issuer)
XOMA Corp (Issuer)
XOMA Corp (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
3:30 PM
WYSZOMIERSKI JACK L (Reporting)
XOMA (Issuer)
XOMA Corp (Issuer)
XOMA Corp (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:31 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:45 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:35 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2024
6:30 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
7:07 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
8:27 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2024
8:06 AM
Kinnate Biopharma Inc. (Subject)
XOMA (Filed by)
XOMA Corp (Filed by)
XOMA Corp (Filed by)
Form SC TO-T/A
04/02/2024
6:50 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form ARS
04/02/2024
6:40 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form DEFA14A
04/02/2024
6:31 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form DEF 14A
03/11/2024
5:56 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form S-4
Registration statement under Securities Act of 1933  
03/08/2024
3:34 PM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/08/2024
6:47 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2024
6:39 AM
XOMA (Filer)
XOMA Corp (Filer)
XOMA Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
3:42 PM
Kinnate Biopharma Inc. (Subject)
XOMA (Filed by)
XOMA Corp (Filed by)
XOMA Corp (Filed by)
Form SC TO-C
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:XOMA) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners